← Back to Search

PCR-based Test

Serology test using blood for COVID-19 (CATCH COVID-19 Trial)

Phase 1
Waitlist Available
Research Sponsored by Texas Cardiac Arrhythmia Research Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

CATCH COVID-19 Trial Summary

This trial will compare how well two types of tests can detect COVID-19 infection, and will also look at how these levels of antibodies change over time.

Eligible Conditions
  • COVID-19
  • Coronavirus

CATCH COVID-19 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
detection of viral infection using serology and viral-RNA detection kits
Secondary outcome measures
Temporal trend of antibodies in blood

CATCH COVID-19 Trial Design

3Treatment groups
Active Control
Group I: Serology test using bloodActive Control1 Intervention
Group II: Viral RNA test using nasopharyngeal swabActive Control1 Intervention
Group III: Viral RNA test using sputumActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Texas Cardiac Arrhythmia Research FoundationLead Sponsor
37 Previous Clinical Trials
13,280 Total Patients Enrolled
4 Trials studying COVID-19
5,260 Patients Enrolled for COVID-19

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~20 spots leftby Apr 2025